A detailed history of Deka Bank Deutsche Girozentrale transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 44,000 shares of MRVI stock, worth $247,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,000
Previous 44,000 -0.0%
Holding current value
$247,280
Previous $309,000 17.48%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$12.5 - $24.78 $8,612 - $17,073
-689 Reduced 1.54%
44,000 $611,000
Q1 2022

Apr 28, 2022

SELL
$24.46 - $40.92 $39,551 - $66,167
-1,617 Reduced 3.49%
44,689 $1.59 Million
Q4 2021

Feb 02, 2022

BUY
$35.0 - $45.94 $1.6 Million - $2.1 Million
45,617 Added 6620.75%
46,306 $1.88 Million
Q2 2021

Aug 05, 2021

BUY
$32.46 - $45.0 $22,364 - $31,005
689 New
689 $29,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $739M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.